Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Sterilization of plga microspheres containing rasagiline mesylate destined to treat parkinson’s disease
- In: Industrial Pharmacy Posters
- At: Lisbon (Portugal) (2010)
- Type: Poster
- Poster code: IPS-P-016
- By: FERNáNDEZ, Marcos (Universidad Complutense de Madrid, Madrid, Spain)
- Co-author(s): Barcia, Emilia (Universidad Complutense de Madrid, MADRID, Spain)
Torres-Suárez, Ana Isabel (Universidad Complutense de Madrid, MADRID, Spain)
Negro, Sofía (Universidad Complutense de Madrid, MADRID, Spain) - Abstract:
BACKGROUND Rasagiline mesylate (RM) is a selective MAO-B inhibitor used in Parkinson's disease. Long term drug delivery devices, such as microspheres, can be beneficial in chronic therapies. Microspheres for parenteral administration have to meet the pharmacopoeial requirements of sterility. In our study, the influence of γ-sterilization was
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023